![Frontiers | A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups Frontiers | A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups](https://www.frontiersin.org/files/Articles/696147/fonc-11-696147-HTML-r1/image_m/fonc-11-696147-g001.jpg)
Frontiers | A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups
![Samsung SSD 870 EVO 2TB 1TB 500G 250GB 2.5" SATA III Solid State Drive W/box lot – ASA College: Florida Samsung SSD 870 EVO 2TB 1TB 500G 250GB 2.5" SATA III Solid State Drive W/box lot – ASA College: Florida](https://i.ebayimg.com/images/g/ihIAAOSwOahkPQ7H/s-l1600.jpg)
Samsung SSD 870 EVO 2TB 1TB 500G 250GB 2.5" SATA III Solid State Drive W/box lot – ASA College: Florida
![Introducing Samsung Wallet: An Easy-To-Use, Secure Platform That Holds Everything Your Digital Life Needs – Samsung Global Newsroom Introducing Samsung Wallet: An Easy-To-Use, Secure Platform That Holds Everything Your Digital Life Needs – Samsung Global Newsroom](https://img.global.news.samsung.com/global/wp-content/uploads/2022/06/SamsungWallet_Thumb728_F.jpg)
Introducing Samsung Wallet: An Easy-To-Use, Secure Platform That Holds Everything Your Digital Life Needs – Samsung Global Newsroom
![Global POS Restaurant Management Systems Market to Reach $18.2 Billion by 2026 - Food & Beverage Magazine Global POS Restaurant Management Systems Market to Reach $18.2 Billion by 2026 - Food & Beverage Magazine](https://www.fb101.com/wp-content/uploads/2022/03/Gambling_Market-1200x1012.jpg)
Global POS Restaurant Management Systems Market to Reach $18.2 Billion by 2026 - Food & Beverage Magazine
![Cancers | Free Full-Text | Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma Cancers | Free Full-Text | Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma](https://www.mdpi.com/cancers/cancers-15-01523/article_deploy/html/images/cancers-15-01523-g001.png)